HomeCompareCNTG vs PLD

CNTG vs PLD: Dividend Comparison 2026

CNTG yields 615.38% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CNTG wins by $317090.34M in total portfolio value
10 years
CNTG
CNTG
● Live price
615.38%
Share price
$0.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$317096.84M
Annual income
$240,286,389,158.92
Full CNTG calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — CNTG vs PLD

📍 CNTG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNTGPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNTG + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNTG pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNTG
Annual income on $10K today (after 15% tax)
$52,307.69/yr
After 10yr DRIP, annual income (after tax)
$204,243,430,785.08/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, CNTG beats the other by $204,238,962,814.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNTG + PLD for your $10,000?

CNTG: 50%PLD: 50%
100% PLD50/50100% CNTG
Portfolio after 10yr
$158551.67M
Annual income
$120,145,822,797.55/yr
Blended yield
75.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CNTG
Analyst Ratings
6
Buy
1
Hold
Consensus: Buy
Price Target
$2.50
+669.2% upside vs current
Range: $2.50 — $2.50
Altman Z
-4.0
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNTG buys
0
PLD buys
0
No recent congressional trades found for CNTG or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNTGPLD
Forward yield615.38%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$317096.84M$6.50M
Annual income after 10y$240,286,389,158.92$5,256,436.18
Total dividends collected$310719.17M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$2.50$136.00

Year-by-year: CNTG vs PLD ($10,000, DRIP)

YearCNTG PortfolioCNTG Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$72,238$61,538.46$11,255$555.24+$61.0KCNTG
2$492,757$415,462.04$13,062$1,018.59+$479.7KCNTG
3$3,175,824$2,648,573.62$15,903$1,926.67+$3.16MCNTG
4$19,351,474$15,953,343.00$20,839$3,823.32+$19.33MCNTG
5$111,556,214$90,850,136.77$30,464$8,166.08+$111.53MCNTG
6$608,830,006$489,464,856.28$52,054$19,457.30+$608.78MCNTG
7$3,147,996,660$2,496,548,553.59$109,886$54,188.93+$3147.89MCNTG
8$15,432,443,240$12,064,086,814.21$304,030$186,451.18+$15432.14MCNTG
9$71,785,467,937$55,272,753,670.42$1,166,125$840,813.32+$71784.30MCNTG
10$317,096,839,852$240,286,389,158.92$6,504,190$5,256,436.18+$317090.34MCNTG

CNTG vs PLD: Complete Analysis 2026

CNTGStock

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Full CNTG Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CNTG vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNTG vs SCHDCNTG vs JEPICNTG vs OCNTG vs KOCNTG vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.